ICYMI, we had a great time contributing to the discussion on precision neurotherapeutics during the 2024 BIO International Convention. It’s always enriching to engage with industry peers to brainstorm innovative approaches to better serve patient needs.
Cerevance’s Post
More Relevant Posts
-
Are you joining us at PSI 2024 next week? Make sure to stop by James Matcham's presentation "Advanced Trial Simulation in the Design of a Pivotal Cardiovascular Study: A Case Study" to discover how Cytel anticipates future developments both in the industry and across your therapeutic journey to ensure you always stay ahead of the curve! Can't make it? Stop by booth 18 any day and speak to our experts! Book a meeting here: https://hubs.ly/Q02B17jn0 #PSI #Biostatistics #HTA
To view or add a comment, sign in
-
RRP is at the table!
Happening this week: Dr. Simon Best, leading laryngologist and a Principal Investigator in INOVIO’s Phase 1/2 trial with INO-3107, is joining CEO Dr. Jacqui Shea and CMO Dr. Mike Sumner for a virtual fireside chat on RRP & INO-3107 as a potential treatment, moderated by Oppenheimer's Hartaj Singh. Replay will be available immediately afterwards at www.inovio.com. Read more here: https://bit.ly/3S71wR8
To view or add a comment, sign in
-
Driven Regulatory Affairs professional with over 25 years experience in the Medical Device industry looking for a remote position
Check out these presentations by Matthew Mace from Acorai to learn about the upcoming alternatives in managing Heart Failure.
Exciting news! Our chief scientific officer, Matthew Mace, will present twice today at the Frankfurt CSI congress First up, catch him at the start-up competition in the Pink room at 16:15 CEST. Matthew will be sharing the latest data from the world of Acorai - you won't want to miss it! Immediately following, join Matthew and some esteemed colleagues in the Yellow Room at 17:30 for a session on other device-based heart failure therapies. Make sure to mark your calendars and attend these presentations. Matthew will be in Frankfurt until the end of the congress on Saturday. See you there! #CSIcongress #Acorai #HeartFailureTherapies #FrankfurtPresentation
To view or add a comment, sign in
-
👏What is our Comprehensive Performance Panel? At PH Performance, we believe that knowing your own personal data is the key to unlocking your full potential. By harnessing your unique data, you gain valuable insights into your body’s capabilities, enabling informed decisions and maximizing your performance and well-being. One of the advanced testing options we offer through PH Performance is the Comprehensive Performance Panel. This includes: ✔️ Extensive laboratory panel evaluating markers of cardiometabolic health, nutrient status, inflammation, hormones, electrolytes, blood counts, & more. ✔️ Review of medical history and in-person or virtual lab interpretation with one of Practical Healing’s Certified Functional Medicine Practitioners. We also offer the comprehensive performance panel inside bundles: 1️⃣Performance Bundle: Inbody + RMR + Performance Panel + 30 minute consultation with Performance coach to review biometric data 2️⃣Athlete Bundle: Inbody + RMR + Performance Panel + VO2 Max + 30 minute Performance coach to review biometric data 👉Learn more: https://lnkd.in/g7KxQdWw
To view or add a comment, sign in
-
This study investigates the feasibility of using QFR in Heart Team discussions for determining optimal revascularization strategies in patients with MVD. It found substantial agreement between the QFR and FFR methods, suggesting that QFR is a viable non-invasive alternative to FFR. This could simplify the decision-making process in clinical settings by reducing reliance on invasive FFR measurements and potentially speeding up procedural times. Taku Asano MD, PhD https://ow.ly/qjN850S3Orv Check out also the Editorial by Patrick W. Serruys; @Pruthvi C. Revaiah 👉 https://ow.ly/pB8550S3OQH
To view or add a comment, sign in
-
ENDO and Member Benefits Orientation Recording with Stephen Hammes, MD, PhD If you missed our inaugural member orientation session, the recording can be accessed through our exclusive online community, EndoForum: https://bit.ly/4aGKWj8 Endocrine Society President Stephen Hammes, MD, PhD, introduced our session with topics ranging from ENDO 2024 and how to maximize membership benefits: https://bit.ly/4aGKWj8 #ENDO2024
To view or add a comment, sign in
-
After encountering resistance from an ampullary stricture, see how this physician uses a double-wire cannulation technique to gain biliary access during ERCP. Watch now – then see how Boston Scientific’s new sphincterotome is designed for difficult cannulation: https://bit.ly/3xsCiFX
Have you faced resistance during biliary cannulation? When performing ERCP, this can be a common challenge to gaining access to the bile duct. See how gastroenterologist Dr. Sumit Singla uses a double-wire technique to help a 61-year-old patient with obstructive jaundice and an ampullary stricture – placing one wire in the pancreatic duct and using the second wire to gain access to the biliary tree. Explore more techniques: https://bit.ly/3VVNa9A Dr. Sumit Singla is a paid consultant of Boston Scientific.
To view or add a comment, sign in
-
Sign-up now for this webinar on May 15th and learn about the most clinically studied, enhanced absorption curcumin in the world, with over 90 published studies. To sign up: https://bit.ly/3wbgBtR
To view or add a comment, sign in
-
Resistance isn’t futile. It’s just another common challenge of biliary cannulation. Explore this double-wire technique to gain biliary access for ERCP – and learn how Boston Scientific’s newest sphincterotome can help you manage difficult cannulation: https://bit.ly/4aJlYQd
Have you faced resistance during biliary cannulation? When performing ERCP, this can be a common challenge to gaining access to the bile duct. See how gastroenterologist Dr. Sumit Singla uses a double-wire technique to help a 61-year-old patient with obstructive jaundice and an ampullary stricture – placing one wire in the pancreatic duct and using the second wire to gain access to the biliary tree. Explore more techniques: https://bit.ly/3VVNa9A Dr. Sumit Singla is a paid consultant of Boston Scientific.
To view or add a comment, sign in
-
Register for tomorrow’s live review of the PI-RADS upgrading rules for Category 3 PI-RADS lesions and an evaluation of the clinical net benefit of the PI-RADS upgrading rules in MRI-directed diagnostic pathways with Leonardo Kayat Bittencourt, MD, PhD. arrs.org/ajrlive
To view or add a comment, sign in
5,011 followers